519 related articles for article (PubMed ID: 24491075)
1. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
[TBL] [Abstract][Full Text] [Related]
2. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
[TBL] [Abstract][Full Text] [Related]
3. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
[TBL] [Abstract][Full Text] [Related]
4. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
Garland EL; Nakamura Y; Bryan CJ; Hanley AW; Parisi A; Froeliger B; Marchand WR; Donaldson GW
Am J Psychiatry; 2024 Feb; 181(2):125-134. PubMed ID: 38196335
[TBL] [Abstract][Full Text] [Related]
5. Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial.
Vowles KE; Witkiewitz K; Cusack KJ; Gilliam WP; Cardon KE; Bowen S; Edwards KA; McEntee ML; Bailey RW
J Pain; 2020; 21(7-8):798-807. PubMed ID: 31760109
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study.
Garland EL; Bryan MA; Priddy SE; Riquino MR; Froeliger B; Howard MO
Ann Behav Med; 2019 Aug; 53(10):865-876. PubMed ID: 30668631
[TBL] [Abstract][Full Text] [Related]
7. Mindfulness-oriented recovery enhancement ameliorates the impact of pain on self-reported psychological and physical function among opioid-using chronic pain patients.
Garland EL; Thomas E; Howard MO
J Pain Symptom Manage; 2014 Dec; 48(6):1091-9. PubMed ID: 24780180
[TBL] [Abstract][Full Text] [Related]
8. Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.
Garland EL; Hudak J; Hanley AW; Nakamura Y
Am Psychol; 2020 Sep; 75(6):840-852. PubMed ID: 32915027
[TBL] [Abstract][Full Text] [Related]
9. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
[TBL] [Abstract][Full Text] [Related]
10. Disrupting the downward spiral of chronic pain and opioid addiction with mindfulness-oriented recovery enhancement: a review of clinical outcomes and neurocognitive targets.
Garland EL
J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):122-9. PubMed ID: 24845547
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
Garland EL; Hanley AW; Kline A; Cooperman NA
Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
[TBL] [Abstract][Full Text] [Related]
12. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
Garland EL; Froeliger B; Howard MO
Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
[TBL] [Abstract][Full Text] [Related]
13. Treating chronic pain: the need for non-opioid options.
Garland EL
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):545-50. PubMed ID: 24918159
[TBL] [Abstract][Full Text] [Related]
14. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT.
Garland EL; Froeliger B; Howard MO
J Behav Med; 2015 Apr; 38(2):327-36. PubMed ID: 25385024
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
Vowles KE; Witkiewitz K; Clarke E; Schmidt Z; Borsari B; Edwards KE; Korecki JR; Moniz-Lewis DI; Bondzie JA; Mullins C; Thoreson CI; Delacruz J; Wilkins CH; Nelson S; Delventura J; Henderson R; Katz A; Hua W; Watson E; Baxley C; Canlas BR; Pendleton T; Herbst E; Batki S
Contemp Clin Trials; 2023 Mar; 126():107096. PubMed ID: 36693589
[TBL] [Abstract][Full Text] [Related]
17. The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.
Garland EL; Froeliger B; Zeidan F; Partin K; Howard MO
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2597-607. PubMed ID: 23988582
[TBL] [Abstract][Full Text] [Related]
18. Mindfulness-Based Therapy Reduces Chronic Pain and Opioid Misuse.
Slomski A
JAMA; 2022 May; 327(17):1641. PubMed ID: 35503359
[No Abstract] [Full Text] [Related]
19. Mindfulness for chronic pain and prescription opioid misuse: novel mechanisms and unresolved issues.
Garland EL; Black DS
Subst Use Misuse; 2014 Apr; 49(5):608-11. PubMed ID: 24611857
[No Abstract] [Full Text] [Related]
20. Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients.
Baker AK; Garland EL
Exp Clin Psychopharmacol; 2019 Feb; 27(1):55-63. PubMed ID: 30265061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
